RAINBOW

company

About

RAINBOW was established with the aim of promoting the development of autologous bone marrow mesenchymal stem cell products

  • 1 - 10

Details

Last Funding Type
Seed
Last Funding Money Raised
¥150M
Industries
Health Care,Medical
Founded date
Aug 9, 2019
Number Of Employee
1 - 10
Operating Status
Active

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
¥150M
RAINBOW has raised a total of ¥150M in funding over 2 rounds. Their latest funding was raised on Oct 26, 2020 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 26, 2020 Seed ¥150M 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
RAINBOW is funded by 2 investors. Hokkaido Research Institute for the Twenty-first Century and Okasan Capital Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Hokkaido Research Institute for the Twenty-first Century Seed
Okasan Capital Partners Seed